2017
DOI: 10.1016/j.bjid.2017.03.001
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Adherence, elevated ALT, and non-vertical transmission are predictors of HBeAg seroconversion in CHB patients treated with NAs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 34 publications
0
2
0
Order By: Relevance
“…Previously suggested factors for HBeAg seroconversion were adherence to HBV medication, high ALT levels and non‐vertical transmission 27 . Baseline predictive factors can assist physicians in the timing and usage of different adjuvant antiviral therapies along with NA treatment.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Previously suggested factors for HBeAg seroconversion were adherence to HBV medication, high ALT levels and non‐vertical transmission 27 . Baseline predictive factors can assist physicians in the timing and usage of different adjuvant antiviral therapies along with NA treatment.…”
Section: Discussionmentioning
confidence: 99%
“…26 Previously suggested factors for HBeAg seroconversion were adherence to HBV medication, high ALT levels and non-vertical transmission. 27 Baseline predictive factors can assist physicians in the timing and usage of different adjuvant antiviral therapies along with NA treatment. This is especially useful in populations where HBV genotype C is dominant; HBV genotype C is associated with a higher tendency of chronicity and a lower tendency to achieve serologic outcomes compared to other subtypes.…”
Section: Discussionmentioning
confidence: 99%